Release of growth factors at wound healing stages
Inventors
Sakon, Joshua • Beitle, Robert • Aljewari, Hazim • Matsushita, Osamu • Beitle, Stephanie
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present invention provides collagen-binding agents that can be used to treat wounds, ischemic heart disease, and other conditions. The collagen-binding agents comprise a therapeutic agent, a protease cleavage site, and a collagen-binding domain. The present invention further provides pharmaceutical compositions and biomedical devices comprising the disclosed collagen-binding agents, as well as methods for treating a condition using the collagen-binding agents.
Core Innovation
The disclosed invention relates to collagen-binding agents that comprise a therapeutic agent, an MMP protease cleavage site for temporally controlled release during wound healing and inflammation, and bacterial-derived collagen-binding domains. The collagen-binding domains can be in tandem as a CBD-CBD configuration to bind exposed collagen lesions at the injury site. The agent is constructed to provide spatial and temporal regulation of delivery.
The therapeutic component includes fibroblast growth factor (FGF) polypeptides, including FGF1/FGF2 and engineered variants. Representative therapeutic agents described include bFGF (FGF2), super human acidic FGF1 (shFGF1), and super human acidic FGF2 (shFGF2), including specific variant identities and engineered forms. A fusion protein format is described for expressing and purifying a bFGF-CBD-CBD fusion protein.
The document further describes pharmaceutical compositions and biomedical device coatings that incorporate the collagen-binding agents. In particular, stent coatings are described as preferred implementations, with the collagen-binding agent included to seek exposed collagen lesions and modulate release during wound healing phases. Experimental support is described for collagen binding, wound-closure effects using a scratch assay, and cell viability with no negative impact, with additional biocompatibility and hemocompatibility testing plans noted.
Claims Coverage
The partial content includes one independent claim (clm-00001). The inventive features in the dependent claims refine this agent into specific compositions and uses, including a wound-treatment administration and a coated biomedical stent configuration.
Collagen-binding agent defined by SEQ ID NO:1
A collagen-binding agent comprising SEQ ID NO:1.
Pharmaceutical composition with pharmaceutically acceptable carrier
A pharmaceutical composition that includes the collagen-binding agent of claim 1 together with a pharmaceutically acceptable carrier.
Method of treating a wound by administering an effective amount
A method of treating a wound by administering the collagen-binding agent of claim 1 to a subject in an effective amount.
Mammal subject for wound treatment
The method is performed on a mammal as the subject.
Coated biomedical stent with biodegradable polymer or collagen
A biomedical device in the form of a stent includes a coating containing the collagen-binding agent of claim 1 and further containing a biodegradable polymer or collagen.
Administering the stent to treat a wound
A method covering administering the biomedical device of claim 5 to a subject to treat a wound.
Overall, the claim coverage centers on a collagen-binding agent defined by SEQ ID NO:1, with refinements directed to a pharmaceutical composition, wound-treatment administration to a subject (including a mammal limitation), and use of the agent in a coated biomedical stent having a biodegradable polymer or collagen in the coating.
Stated Advantages
No negative impact on cell viability is reported in the described example support.
Documented Applications
Treating a wound by administering the collagen-binding agent to a subject in an effective amount.
Using a coated biomedical stent with the collagen-binding agent to treat a wound.
Interested in licensing this patent?